Gsk (GSK) Other Non-Current Liabilities (2009 - 2026)
Gsk (GSK) posted Other Non-Current Liabilities of $1.4 billion for Q4 2025, down 3.62% on a QoQ basis from $1.4 billion in Q4 2024, and down 3.62% year-over-year from $1.4 billion in Q4 2024.
Gsk (GSK) has 10 years of Other Non-Current Liabilities data on file, last reported at $1.4 billion in Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 3.62% year-over-year to $1.4 billion; the TTM figure through Dec 2025 stood at $1.4 billion (down 3.62% YoY), while the FY2025 annual figure was $1.4 billion, down 3.62% from the prior year.
- Other Non-Current Liabilities slipped to $1.4 billion in Q4 2025, from $1.4 billion in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.4 billion in Q4 2024 and bottomed at $1.1 billion in Q4 2022.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities fell 15.07% — and 2023, when it jumped 30.3%.
- Year by year, Other Non-Current Liabilities stood at $1.2 billion in 2021, then declined by 15.07% to $1.1 billion in 2022, then jumped by 30.3% to $1.4 billion in 2023, then increased by 2.76% to $1.4 billion in 2024, then fell by 3.62% to $1.4 billion in 2025.
- The last three Other Non-Current Liabilities figures came in at $1.4 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.4 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40 Bn |
| Dec 31, 2025 | -1.36 Bn |
| Sep 30, 2025 | -1.38 Bn |
| Jun 30, 2025 | -1.33 Bn |
| Mar 31, 2025 | -1.30 Bn |
| Dec 31, 2024 | 1.41 Bn |
| Sep 30, 2024 | -1.35 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Sep 30, 2023 | -1.35 Bn |
| Jun 30, 2023 | -1.13 Bn |
| Mar 31, 2023 | -1.08 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | -1.05 Bn |
| Jun 30, 2022 | -1.11 Bn |
| Mar 31, 2022 | -8.05 Mn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | -1.14 Bn |
| Jun 30, 2021 | -1.13 Bn |
| Mar 31, 2021 | -1.08 Bn |
| Dec 31, 2020 | 1.06 Bn |
| Jun 30, 2020 | -1.03 Bn |
| Mar 31, 2020 | -985.75 Mn |
| Dec 31, 2019 | 1.09 Bn |
| Sep 30, 2019 | -1.09 Bn |
| Jun 30, 2019 | -1.13 Bn |
| Mar 31, 2019 | -1.09 Bn |
| Dec 31, 2018 | 1.21 Bn |
| Sep 30, 2018 | -1.35 Bn |
| Jun 30, 2018 | -1.34 Bn |
| Mar 31, 2018 | -1.29 Bn |
| Dec 31, 2017 | 1.30 Bn |
| Sep 30, 2017 | -1.28 Bn |
| Jun 30, 2017 | -1.28 Bn |
| Mar 31, 2017 | -10.62 Bn |
| Dec 31, 2016 | 10.50 Bn |
| Sep 30, 2016 | -12.51 Bn |
| Jun 30, 2016 | -13.25 Bn |
| Mar 31, 2016 | -17.49 Bn |
| Dec 31, 2015 | -10.78 Bn |
| Sep 30, 2015 | -15.55 Bn |
| Jun 30, 2015 | -14.90 Bn |
| Mar 31, 2015 | -14.64 Bn |
| Dec 31, 2014 | -3.80 Bn |
| Sep 30, 2014 | -3.46 Bn |
| Jun 30, 2014 | -2.95 Bn |
| Mar 31, 2014 | -2.88 Bn |
| Dec 31, 2013 | -2.76 Bn |
| Sep 30, 2013 | -2.48 Bn |
| Jun 30, 2013 | -2.44 Bn |
| Mar 31, 2013 | -2.31 Bn |
| Dec 31, 2012 | 38.54 Mn |
| Sep 30, 2012 | -1.27 Bn |
| Jun 30, 2012 | -961.22 Mn |
| Mar 31, 2012 | -947.37 Mn |
| Dec 31, 2011 | 33.00 Mn |
| Sep 30, 2011 | -937.25 Mn |
| Jun 30, 2011 | -1.00 Bn |
| Mar 31, 2011 | -996.05 Mn |
| Dec 31, 2010 | -938.45 Mn |
| Sep 30, 2010 | -899.29 Mn |
| Jun 30, 2010 | -886.64 Mn |
| Mar 31, 2010 | -958.31 Mn |
| Dec 31, 2009 | -988.25 Mn |
| Sep 30, 2009 | -730.16 Mn |
| Jun 30, 2009 | -607.01 Mn |
| Mar 31, 2009 | -583.41 Mn |